Stock Events

Stock Events

KalVista Pharmaceuticals (KALV) Q3 2025 Earnings

10JulConfirmed

Q3 2024

Q4 2024

Q1 2025

Q3 2025

-0.99

-0.93

-0.86

-0.8

Details

Expected EPS

-0.798889

Actual EPS

-0.99

Surprise EPS

-0.19

Surprise Percent

+23.92%

Description

KalVista Pharmaceuticals (KALV) has reported earnings of -0.99 per share for Q3 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.